With regards to CDK1, it was reported that inhibition of MDM2 with nutlin and blockage of iASPP phosphorylation using a cyclin B1/CDK1 inhibitor activated p53 in melanoma cells (Lu et al., 2013). Here, CDK1 is linked to melanoma.